Transcriptomic analysis of the regulatory mechanism of lipocalin-2 in silicosis inflammation
环境与职业医学 · 2026-06 · 43 (6) · 702-708
DOI: 10.11836/jeom25519 ↗Kurz gefasst
Fachartikel in der Zeitschrift 环境与职业医学, 2026-06. Verfasst von Yanan SUN und 7 weiteren Autor:innen.
Abstract (Originalsprache)
BackgroundLung tissue fibrosis caused by exposure to free silica (SiO2) dust is the core pathological feature of silicosis. Lipocalin-2 (LCN2), as a secreted glycoprotein, plays an important role in various inflammatory diseases, but its specific role in silicosis-induced inflammatory injury remains unclear.ObjectiveTo identify differentially expressed genes (DEGs) and enriched pathways in the lung tissues of rats with silicosis, and to explore the regulatory mechanism of LCN2 in silicosis inflammation.MethodsTwenty specific pathogen-free male SD rats were randomly divided into a control group and a silicosis model group (n=10 per group). The silicosis model was established via a single intratracheal instillation of silicon dioxide (SiO2) suspension (50 mg), while the control group received an equal volume of normal saline. In vitro, NR8383 cells were divided into a control group and a SiO2 treatment group. Hematoxylin-eosin (HE) staining and Van Gieson (VG) staining were used to evaluate alveolar structure damage, inflammatory infiltration, and collagen deposition in the lung tissues. Transcriptomic sequencing was applied to screen for DEGs and enriched signaling pathways. Western blot was used to detect the protein expression of interleukin-6 (IL-6), E-cadherin (ECA), cluster of differentiation 36 (CD36), liver X receptor (LXR), ATP-binding cassette transporter A1 (ABCA1), and LCN2 in both rat lung tissues and NR8383 cells. Immunohistochemistry was used to further assess LCN2 expression and localization. Additionally, NR8383 cells were treated with the LCN2 inhibitor ZINC00640089 and assigned to four groups: control, ZINC00640089-only, SiO2, and SiO2+ZINC00640089. Western blot was used to evaluate the expression of LCN2, IL-6, and interleukin-1β (IL-1β).ResultsHE and VG staining revealed disorganized lung tissue structure, damaged alveolar walls, nodule formation, and increased collagen deposition in the silicosis model group compared to the controls. Transcriptomic analysis identified 2723 DEGs in the lung tissues of silicosis rats (312 down-regulated and 2411 up-regulated) with LCN2 expression being significantly up-regulated. These DEGs were primarily enriched in pathways related to the innate immune response, extracellular matrix (ECM)-receptor interaction, and inflammatory response. Immunohistochemical staining confirmed elevated LCN2 levels in the lung tissues of the model rats. Western blot demonstrated that the protein levels of IL-6, CD36, and LCN2 were significantly increased (P
Schlagwörter
Zitieren
APA
SUN, Y., ZHANG, Y., WANG, X., WAN, F., LIU, H., WANG, H., YAO, S., & HE, H. (2026). Transcriptomic analysis of the regulatory mechanism of lipocalin-2 in silicosis inflammation. 环境与职业医学, 43(6), 702-708. https://doi.org/10.11836/jeom25519
Vancouver
SUN Y, ZHANG Y, WANG X, WAN F, LIU H, WANG H, et al. Transcriptomic analysis of the regulatory mechanism of lipocalin-2 in silicosis inflammation. 环境与职业医学. 2026;43(6):702-708. doi:10.11836/jeom25519
BibTeX
@article{SUN2026,
author = {SUN, Yanan and ZHANG, Yue and WANG, Xinyao and WAN, Fangze and LIU, Heliang and WANG, Hongli and YAO, Sanqiao and HE, Hailan},
title = {Transcriptomic analysis of the regulatory mechanism of lipocalin-2 in silicosis inflammation},
journal = {环境与职业医学},
year = {2026},
volume = {43},
number = {6},
pages = {702--708},
doi = {10.11836/jeom25519}
}
EUVIMED